Statin use and risk of prostate cancer in a population of men who underwent biopsy

Journal of Urology

Volumn 186, Issue 1, 2011, Pages 86-90

  Tan, Nelly ^a,b   Klein, Eric A ^a   Li, Jianbo ^a   Moussa, Ayman S ^a   Jones, J Stephen ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

hydroxymethylglutaryl CoA reductase inhibitors; prostatic neoplasms

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; PROSTATE SPECIFIC ANTIGEN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER GRADING; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; DRUG USE; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; ORGAN SIZE; OUTPATIENT CARE; PHARMACY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RACE; RETROSPECTIVE STUDY; TREATMENT DURATION;

AGED; BIOPSY; COHORT STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; ORGAN SIZE; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79958280101     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.03.004     Document Type: Article

References (29)

1. G.L. Andriole, E.D. Crawford, and R.L. Grubb 3rd Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310
2. R.L. Grubb 3rd, P.F. Pinsky, and R.T. Greenlee Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial BJU Int 102 2008 1524
3. W.W. Wong, J. Dimitroulakos, and M.D. Minden HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis Leukemia 16 2002 508
4. A. Hoque, H. Chen, and X.C. Xu Statin induces apoptosis and cell growth arrest in prostate cancer cells Cancer Epidemiol Biomarkers Prev 17 2008 88
5. I. Agalliu, C.A. Salinas, and P.D. Hansten Statin use and risk of prostate cancer: results from a population-based epidemiologic study Am J Epidemiol 168 2008 250
6. E.J. Jacobs, C. Rodriguez, and E.B. Bain Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort Cancer Epidemiol Biomarkers Prev 16 2007 2213
7. T.J. Murtola, T.L. Tammela, and J. Lahtela Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study Cancer Epidemiol Biomarkers Prev 16 2007 2226
8. E.D. Flick, L.A. Habel, and K.A. Chan Statin use and risk of prostate cancer in the California Men's Health Study cohort Cancer Epidemiol Biomarkers Prev 16 2007 2218
9. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in AdultsThe Evidence Report National Institutes of Health Obes Res 6 suppl 1998 51S
10. J.I. Epstein, W.C. Allsbrook Jr, and M.B. Amin The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228
11. N. Tan, B.R. Lane, and J. Li Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade J Urol 180 2008 1325
12. S.J. Freedland, G.S. Csathy, and F. Dorey Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score J Urol 167 2002 516
13. J.I. Epstein, P.C. Walsh, and M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368
14. R.J. Hamilton, K.C. Goldberg, and E.A. Platz The influence of statin medications on prostate-specific antigen levels J Natl Cancer Inst 100 2008 1511
15. T.J. Murtola, T.L. Tammela, and L. Mttnen Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial Int J Cancer 127 2010 1650
16. L.S. Krane, S.A. Kaul, and H.J. Stricker Men presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen J Urol 183 2010 118
17. S.J. Lee, M.J. Ha, and J. Lee Inhibition of the 3-hydroxy-3- methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells J Biol Chem 273 1998 10618
18. C. Park, I. Lee, and W.K. Kang Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death Carcinogenesis 22 2001 1727
19. S. Friis, A.H. Poulsen, and S.P. Johnsen Cancer risk among statin users: a population-based cohort study Int J Cancer 114 2005 643
20. R.H. Breau, R.J. Karnes, and D.J. Jacobson The association between statin use and the diagnosis of prostate cancer in a population based cohort J Urol 184 2010 494
21. T.J. Murtola, P. Pennanen, and H. Syvala Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations Prostate 69 2009 1017
22. E.A. Platz, M.F. Leitzmann, and K. Visvanathan Statin drugs and risk of advanced prostate cancer J Natl Cancer Inst 98 2006 1819
23. J. Shannon, S. Tewoderos, and M. Garzotto Statins and prostate cancer risk: a case-control study Am J Epidemiol 162 2005 318
24. S. Loeb, D. Kan, and B.T. Helfand Is statin use associated with prostate cancer aggressiveness? BJU Int 105 2010 1222
25. M.R. Freeman, and K.R. Solomon Cholesterol and prostate cancer J Cell Biochem 91 2004 54
26. E.A. Platz, S.K. Clinton, and E. Giovannucci Association between plasma cholesterol and prostate cancer in the PSA era Int J Cancer 123 2008 1693
27. E.A. Platz, C. Till, and P.J. Goodman Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial Cancer Epidemiol Biomarkers Prev 18 2009 2807
28. Gutt R, Tonlaar N, Kunnavakkam R, et al. Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. J Clin Oncol 28: 2653.
29. Hamilton RJ, Banez LL, Aronson WJ, et al. Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Cancer 116: 3389.